Drug Development

Brandon Haschke is a product manager for Emerson's Rosemount instrumentation business. 

Articles

Single-use processing requires instruments providing the accuracy of traditional technologies but configured in form factors designed specifically for this service

Instrumenting Single-Use Processes

A variety of assays should be used to detect bacterial, fungal, and viral contaminants in the human source cells used for cell therapies.

Detecting Contamination in Cell Therapies

Santen Pharmaceutical has concluded a licensing agreement with jCyte for the development, registration, and commercialization rights to jCell, an investigational retinitis pigmentosa therapy, in Japan, Asia, and Europe.


Santen, jCyte Sign Licensing Contract for Investigational Retinitis Pigmentosa Therapy

The Coalition for Epidemic Preparedness Innovations will invest up to $384 million of additional funding, in addition to the $4 million it invested in March, to advance the clinical development of NVX-CoV2373, Novavax’s COVID-19 vaccine candidate.

Novavax to Receive up to $384 Million in Funding from CEPI for COVID-19 Vaccine Candidate

Catalent will manufacture a mRNA-based COVID-19 vaccine for clinical trials and potential commercialization.

Catalent, Arcturus Therapeutics Sign Vaccine Deal

Trial begins in the US for the Pfizer-BioNTech mRNA COVID-19 vaccine; manufacturing plans announced.

Initial US Patients Dosed in mRNA Vaccine Trial

The extension of the company’s product offerings to include the anti-certolizumab pegol antibodies offers critical reagents for the development of assays for TNF alpha inhibitor biologics and their biosimilars.

Bio-Rad Launches Anti-Certolizumab Pegol Antibodies

Kindeva Drug Delivery plans capital investment and jobs growth.

Former 3M Drug Delivery Systems Launches as Kindeva Drug Delivery

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Will moving at “warp speed” to develop a vaccine impact efficacy or safety?

How Fast Is Too Fast?

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

In light of the hype around chloroquine and hydroxychloroquine as potential COVID-19 treatments, it is important to remember that drug repurposing should never be rushed, irrespective of the urgency of the situation.

Formulation and Drug Delivery